The data show that the catalytic parameter, namely, the ratio of the rates of the hydrolysis of two substrates hydrolyzed by the two active centers of ACE with different efficiency, ZPHL/HHL ratio [27], and the ratio of immunoreactive ACE protein to ACE activity have been significantly increased in patients with PC. This evidence concerns the gene ACE and pachyonychia congenita.